Estimated reading time: 1 minutes
A study found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of a specific protein in the brain.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.